Back to search

Article

Uncoupling of CSF biomarkers and clinical status in patients with a novel mutation of ATP13a2

2025-09-05

Abstract excerpt

<h4>Summary</h4> Cerebrospinal fluid (CSF) biomarkers are generally assumed to reflect the severity and progression of neurodegenerative disease. We report three siblings carrying a novel heterozygous ATP13A2 variant (p.Pro629Ser) who challenge this paradigm. Despite only slowly progressive cognitive decline, axonal neuropathy, and leukodystrophy on MRI, all established CSF markers of neuronal destruction were pr...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
67a2c172-cf04-536d-b94b-79e3c20cf328
DOI
10.1101/2025.09.02.25334661
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Uncoupling of CSF biomarkers and clinical status in patients with a novel mutation of ATP13a2DOI 10.1101/2025.09.02.25334661
Select a neighboring publication to make it the new centre.